U.S. Army Researchers Announce Phase 2 Clinical Trial For Experimental Ebola Vaccine

Health.mil: Army researchers making critical advances in global health with development of Ebola vaccine
“The Walter Reed Army Institute of Research (WRAIR) recently announced the initiation of a Phase 2 clinical trial to evaluate the safety and effectiveness of two potential Ebola vaccine candidates. The trial represents a significant step forward in the quest to curb future outbreaks of the disease…” (1/28).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.